| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.11▼ | 2.11▼ | 2.12▼ | 2.13▼ | 2.30▼ |
| MA10 | 2.11▼ | 2.13▼ | 2.13▼ | 2.10▼ | 2.65▼ |
| MA20 | 2.12▼ | 2.14▼ | 2.13▼ | 2.38▼ | 2.85▼ |
| MA50 | 2.14▼ | 2.13▼ | 2.08▲ | 2.79▼ | 2.40▼ |
| MA100 | 2.14▼ | 2.08▲ | 2.22▼ | 2.89▼ | 10.75▼ |
| MA200 | 2.13▼ | 2.27▼ | 2.67▼ | 2.41▼ | 18.45▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.007▼ | -0.006▼ | 0.006▲ | -0.051▼ |
| RSI | 30.245▼ | 39.797▼ | 45.449▼ | 36.209▼ | 39.096▼ |
| STOCH | 33.333 | 2.381▼ | 11.376▼ | 43.341 | 10.589▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -79.104▼ | -95.364▼ |
| CCI | -105.415▼ | -130.739▼ | -166.202▼ | -17.139 | -116.043▼ |
|
Monday, September 29, 2025 05:00 PM
Fintel reports that on October 6, 2025, LUCID CAPITAL MARKETS initiated coverage of Cassava Sciences (NasdaqCM:SAVA) with a Buy recommendation. As of September 30, 2025, the average one-year price ...
|
|
Monday, March 31, 2025 07:00 AM
Cassava Sciences SAVA recently suffered yet another setback, which raises concern regarding its prospects. Last week, the company announced that the phase III study REFOCUS-ALZ on lead pipeline ...
|
|
Wednesday, March 26, 2025 07:03 AM
Cassava Sciences stock crashed after the company announced that the late-stage study REFOCUS-ALZ on lead pipeline candidate, simufilam, in mild-to-moderate Alzheimer’s disease (AD) did not show a ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/01/26 | 2.14 | 2.21 | 2.10 | 2.10 | 552,600 |
| 08/01/26 | 2.16 | 2.19 | 2.12 | 2.14 | 594,600 |
| 07/01/26 | 2.14 | 2.28 | 2.13 | 2.18 | 1,091,500 |
| 06/01/26 | 2.10 | 2.15 | 2.07 | 2.12 | 553,300 |
| 05/01/26 | 2.12 | 2.16 | 2.06 | 2.10 | 819,400 |
| 02/01/26 | 2.00 | 2.09 | 1.97 | 2.09 | 596,600 |
| 31/12/25 | 2.01 | 2.02 | 1.96 | 1.98 | 984,400 |
| 30/12/25 | 2.09 | 2.09 | 2.01 | 2.03 | 938,845 |
| 29/12/25 | 2.15 | 2.22 | 2.07 | 2.09 | 805,000 |
| 26/12/25 | 2.22 | 2.24 | 2.16 | 2.18 | 537,800 |
|
|
||||
|
|
||||
|
|